Skip to content
OpenCapital
Get started

Scilex Holding Company SCLX Return on equity

Return on equity at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
27.4%+8.2pp
Viatris logo
ViatrisVTRS
-2%-0.9pp
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
174.1%—
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
100.7%+60.3pp
Opko Health logo
Opko HealthOPK
-16.9%-21.7pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-325.6%+36.9pp

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K—
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.7%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%—

Returns & leverage

See full
Debt / equity0.3×—
Current ratio0.1×0.0×